GenePOC™ Carba 133499
GenePOC Carba 133499, a multiple antimicrobial resistance nucleic acid IVD (FDA Class II) made by Genepoc, Inc., was listed in FDA GUDID on 24 May 2019 (UDI-DI 00628055344070); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00628055344070 | Date24 May 2019 | StatusListed |
Official records
- AccessGUDID record 00628055344070
From the FDA record
- Device description
- The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR). The GenePOC Carba assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative GenePOC Carba assay result does not preclude the presence of other resistance mechanisms. The GenePOC Carba assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- GenePOC™ Carba
- Generic name
- Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 133499
- Primary DI / UDI-DI
- 00628055344070
- FDA product code
- OOI, PMY
- GMDN term
- Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class II
- Regulation number
- 862.2570, 866.1640
- GUDID distribution status
- Not in Commercial Distribution
Similar devices
Other devices filed under FDA product code OOI (Real Time Nucleic Acid Amplification System).
- BD MAX™ System 441916 by Becton, Dickinson and Company
- Alinity m 09N12-001 by Abbott Molecular
- NUCLISENS EASYQ ENTEROVIRUS V1.1., NUCLISENS EASYQ DIRECTOR 2.6, NUCLISENS EASYQ ANALYZER, NUCLISENS MINIMAG by BIOMERIEUX, INC.
- QUANTSTUDIO DX REAL-TIME PCR INSTRUMENT by Life Technologies Corporation
- Exicycler™ V5 384 Fast A-2065-4 by Bioneer Corporation
- Alinity m 09N26-001 by Abbott Molecular
- Panther Fusion® PARAFLU CTRLS KIT, PANTHER FUSION, IVD PRD-04337 by Hologic
- ID NOW™ Instrument EQ00200X by Alere Scarborough, Inc.
- BD Viper™ LT System SDA Accessory Kit 442958 by Becton, Dickinson and Company
- Panther Fusion® PRD-07121 by Hologic